1. Evaluation of mobility recovery after hip fracture: a scoping review of randomized controlled studies

   • K. Taraldsen
   • A. Polhemus
   • B. Vereijken

   Review Open access 06 October 2023 Pages: 203 - 215

   

2. The terminologies of transient, migratory, or localized osteoporosis, and bone marrow edema syndrome: a scoping review

   • Lars Grøvle
   • Anne Julsrud Haugen
   • Eivind Hasvik

   Review Open access 09 October 2023 Pages: 217 - 226

   

3. Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis

   • Rhian Milton-Cole
   • Kareema Kazeem
   • Katie Jane Sheehan

   Review 13 October 2023 Pages: 227 - 242

   

4. The influence of iron on bone metabolism disorders

   • Hui Zhang
   • Fan Yang
   • Mingyong Wang

   Review 19 October 2023 Pages: 243 - 253

   

5. The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial

   • Sabashini K. Ramchand
   • Joy N. Tsai
   • Benjamin Z. Leder

   Original Article 06 October 2023 Pages: 255 - 263

   

6. Performance of FRAX in older adults with frailty: the Framingham Heart Study

   • Tanchanok Chattaris
   • Laiji Yang
   • Sarah D. Berry

   Original Article 24 October 2023 Pages: 265 - 275

   

7. Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment

   • Nicolas Plais
   • Jesús Gallego Bustos
   • Luis Alvarez-Galovich

   Original Article 13 October 2023 Pages: 277 - 284

   

8. Risk of wrist fracture, estimated by the load-to-strength ratio, declines following sleeve gastrectomy in adolescents and young adults

   • Deborah M. Mitchell
   • Vibha Singhal
   • Miriam A. Bredella

   Original Article 21 October 2023 Pages: 285 - 291

   

9. Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data

   • N. Li
   • J. P. van den Bergh
   • M. Hiligsmann

   Original Article Open access 03 October 2023 Pages: 293 - 307

   

10. Improvement of proportion of days covered for denosumab under implementation of clinical pharmacist adherence management system: normal and COVID-19 period

    • Qiong Yang
    • Junhong He
    • Fangfang Yuan

    Original Article Open access 06 October 2023 Pages: 309 - 316

    

11. Epidemiology of distal radius fractures in Germany - incidence rates and trends based on inpatient and outpatient data

    • Kevin Reiland
    • Burkhard Haastert
    • Silke Andrich

    Original Article Open access 11 October 2023 Pages: 317 - 326

    

12. Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids

    • Emely Loscalzo
    • Julia See
    • Janet L. Crane

    Original Article Open access 23 October 2023 Pages: 327 - 338

    

13. Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women

    • S. Han
    • S. Kim
    • H.S. Suh

    Original Article 25 October 2023 Pages: 339 - 352

    

14. Vaccination against COVID-19 reduced the mortality risk of COVID-positive hip fracture patients to baseline levels: the nationwide data-linked IMPACT Protect study

    • Andrew J. Hall
    • N. D. Clement
    • A. D. Duckworth

    Original Article 28 October 2023 Pages: 353 - 363

15. The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection

    • Polyzois Makras
    • Maria P. Yavropoulou
    • Athanasios D. Anastasilakis

    Short Communication 02 October 2023 Pages: 365 - 370

    

16. Correction to: The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial

    • Sabashini K. Ramchand
    • Joy N. Tsai
    • Benjamin Z. Leder

    Correction 09 November 2023 Pages: 371 - 371